A large UK study has opened the door to new pinprick blood tests that could detect diseases more than 10 years before symptoms appear, according to researchers.
The breakthrough follows the completion of a major project by the UK Biobank, which measured nearly 250 proteins, fats, sugars and other molecules in blood samples from 500,000 volunteers. These detailed molecular profiles offer a clear picture of a person’s health. When combined with medical records, they allow scientists to predict the risk of conditions such as diabetes, heart disease, cancer and dementia.
Dr. Joy Edwards-Hicks of the University of Edinburgh said the findings will shift healthcare toward prevention. “It’s going to be a real gamechanger,” she said. With a simple pinprick sample, doctors could give people early warnings and recommend lifestyle changes decades before illness develops.
The UK Biobank worked with Nightingale Health to analyse hundreds of blood metabolites, including amino acids, sugars, fats, hormone precursors and waste products like urea. These molecules reflect how the body processes food and medicines, uses energy and repairs tissues.
When organs begin to fail, metabolic patterns shift. A diseased liver may raise ammonia levels. Kidney damage can increase urea and creatine. Muscle injury may cause a rise in lactate. Cancer often increases glucose uptake. Because metabolites are shaped by genetics and by lifestyle factors such as diet, exercise, pollution and stress, they give a richer picture of health than many traditional tests.
Dr. Julian Mutz of King’s College London explained that metabolic profiles capture both inherited risk and environmental influences. “It gives us a snapshot of a person’s physiological state,” he said, noting that metabolite levels change over time, unlike fixed genetic information.
Although some metabolic data were previously available, the full set of 500,000 profiles will help scientists develop more accurate early-detection tools for a wider range of diseases.
Mutz’s team uses metabolic data to predict dementia risk. If tests can identify high-risk individuals 10 to 15 years earlier, doctors may be able to delay or prevent the disease. The expanded dataset could also improve predictions for rarer disorders such as frontotemporal dementia.
At the University of Oxford, Dr. Najaf Amin and colleagues analysed the new dataset and found clear differences in how men and women age, influencing their risks of cancer and other age-related diseases. They now plan to study how medication effects vary between males and females.
Since 2006, the UK Biobank has recruited volunteers to help scientists study the links between lifestyle, genetics, environment and disease. With the addition of full metabolic profiles, researchers now have an even stronger tool for tracking early warning signs, understanding how illnesses develop, and monitoring treatment responses.
Prof. Naomi Allen, the Biobank’s chief scientist, said metabolic research offers “a powerful way to unveil new warning signs of disease and understand how illnesses start and evolve.”
Related topics
